000125828 001__ 125828
000125828 005__ 20240228143334.0
000125828 0247_ $$2doi$$a10.1007/s00125-015-3773-7
000125828 0247_ $$2pmid$$apmid:26433941
000125828 0247_ $$2ISSN$$a0012-186X
000125828 0247_ $$2ISSN$$a1432-0428
000125828 0247_ $$2altmetric$$aaltmetric:4867641
000125828 037__ $$aDKFZ-2017-01952
000125828 041__ $$aeng
000125828 082__ $$a610
000125828 1001_ $$0P:(DE-HGF)0$$aFlorath, Ines$$b0$$eFirst author
000125828 245__ $$aType 2 diabetes and leucocyte DNA methylation: an epigenome-wide association study in over 1,500 older adults.
000125828 260__ $$aBerlin$$bSpringer$$c2016
000125828 3367_ $$2DRIVER$$aarticle
000125828 3367_ $$2DataCite$$aOutput Types/Journal article
000125828 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1522050478_9783
000125828 3367_ $$2BibTeX$$aARTICLE
000125828 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000125828 3367_ $$00$$2EndNote$$aJournal Article
000125828 520__ $$aDevelopment of type 2 diabetes depends on environmental and genetic factors. We investigated the epigenome-wide association of prevalent diabetes with DNA methylation (DNAm) in peripheral blood.DNAm was measured in whole blood with the Illumina Infinium HumanMethylation450 BeadChip in two subsamples of participants from the ESTHER cohort study. Cohort 1 included 988 participants, who were consecutively recruited between July and October 2000 and cohort 2 included 527 randomly selected participants. The association of DNAm with prevalent type 2 diabetes at recruitment was estimated using median regression analysis adjusting for sex, age, BMI, smoking behaviour, cell composition and batch at 361,922 CpG sites.Type 2 diabetes was prevalent in 16% of the participants, and diabetes was poorly controlled in 45% of the diabetic patients. In cohort 1 (discovery) DNAm at 39 CpGs was significantly associated with prevalent diabetes after correction for multiple testing. In cohort 2 (replication) at one of these CpGs, DNAm was still significantly associated. Decreasing methylation levels at cg19693031 with increasing fasting glucose and HbA1c concentrations were observed using restricted cubic spline analysis. In diabetic patients with poorly controlled diabetes, the decrease in estimated DNAm levels was approximately 5% in comparison with participants free of diagnosed diabetes.Cg19693031, which is located within the 3-untranslated region of TXNIP, might play a role in the pathophysiology of type 2 diabetes. This result appears biologically plausible given that thioredoxin-interacting protein is overexpressed in diabetic animals and humans and 3-untranslated regions are known to play a regulatory role in gene expression.
000125828 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000125828 588__ $$aDataset connected to CrossRef, PubMed,
000125828 650_7 $$2NLM Chemicals$$a3' Untranslated Regions
000125828 650_7 $$2NLM Chemicals$$aBlood Glucose
000125828 650_7 $$2NLM Chemicals$$aCarrier Proteins
000125828 650_7 $$2NLM Chemicals$$aTXNIP protein, human
000125828 7001_ $$0P:(DE-He78)7ca7eafba864e5c3ebb7598149380452$$aButterbach, Katja$$b1$$udkfz
000125828 7001_ $$0P:(DE-He78)d3e4e449f4ed4d38e6ec44362e89dbc8$$aHeiss, Jonathan$$b2$$udkfz
000125828 7001_ $$0P:(DE-He78)7999346780553d7fab7ba69d5afdfa71$$aBewerunge-Hudler, Melanie$$b3$$udkfz
000125828 7001_ $$0P:(DE-He78)6a8f87626cb610618a60d742677284cd$$aZhang, Yan$$b4$$udkfz
000125828 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b5$$udkfz
000125828 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b6$$eLast author$$udkfz
000125828 773__ $$0PERI:(DE-600)1458993-x$$a10.1007/s00125-015-3773-7$$gVol. 59, no. 1, p. 130 - 138$$n1$$p130 - 138$$tDiabetologia$$v59$$x1432-0428$$y2016
000125828 909CO $$ooai:inrepo02.dkfz.de:125828$$pVDB
000125828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000125828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7ca7eafba864e5c3ebb7598149380452$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000125828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d3e4e449f4ed4d38e6ec44362e89dbc8$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000125828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7999346780553d7fab7ba69d5afdfa71$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000125828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6a8f87626cb610618a60d742677284cd$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000125828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000125828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000125828 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000125828 9141_ $$y2016
000125828 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000125828 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000125828 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000125828 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000125828 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bDIABETOLOGIA : 2015
000125828 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000125828 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000125828 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000125828 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000125828 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000125828 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000125828 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000125828 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bDIABETOLOGIA : 2015
000125828 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000125828 9201_ $$0I:(DE-He78)W110-20160331$$kW110$$lMicroarray Unit$$x1
000125828 9201_ $$0I:(DE-He78)G110-20160331$$kG110$$lPräventive Onkologie$$x2
000125828 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x3
000125828 980__ $$ajournal
000125828 980__ $$aVDB
000125828 980__ $$aI:(DE-He78)C070-20160331
000125828 980__ $$aI:(DE-He78)W110-20160331
000125828 980__ $$aI:(DE-He78)G110-20160331
000125828 980__ $$aI:(DE-He78)L101-20160331
000125828 980__ $$aUNRESTRICTED